Industry Research Reports
Home > Reports > Chemical & Material > Global EUV Pellicle Market Outlook, In‑Depth Analysis & Forecast to 2031
Global EUV Pellicle Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-11-08
Pages: 130 Pages
Report ld: 5385562
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
EUV Pellicle Market Size(US$)
CAGR 2025-2031
8.6%
Market Size,2031
USD 171
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 104 million
Market Forecast in 2031(Value)
US$ 171 million
CAGR
8.6%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global EUV Pellicle market is projected to grow from US$ 78.8 million in 2024 to US$ 171 million by 2031, at a CAGR of 8.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
In a typical semiconductor process, a thin protective film is usually placed on the surface of the photomask to protect it from contaminants. This thin film, called a pellicle, prevents undesirable conditions or defects in the wafer circuit pattern, thereby protecting the IC chip from potential damage. In addition, the mask protective film is also a consumable that needs to be replaced regularly, and because the light source wavelength of EUV lithography equipment is shorter, the protective film needs to be thinner to increase light transmittance.
Initially, the film was a single-layer structure with a core layer made of polysilicon. Since 2021, EUV pellicle have adopted composite materials. Its key components now consist of alternating molybdenum disilicide (MoSi₂) and silicon (Si) layers to form a multi-layer structure. EUV transmittance (EUVT) is a key performance indicator of EUV pellicle. The transition from a single-layer structure to a multi-layer structure has increased EUVT from about 82% to about 90%. The next generation of film technology will go beyond structural changes (from single-layer to multi-layer) and introduce material advances, leading to the emergence of CNT pellicle.
Driven by advances in artificial intelligence (AI) and computing technology, the semiconductor industry's demand for advanced chips continues to grow, with the fastest growth in chips below 7nm manufactured using EUV technology. In advanced processes of 7nm and below, the pattern size on the mask may be only tens of nanometers, which places extremely strict requirements on the uniformity and defect control of the Pellicle. The next generation of high-power EUV lithography machines operates at more than 500W, and EUV films are needed to protect the photomask from particle contamination during chip production.
In recent years, the phenomenon of chipmakers adopting extreme ultraviolet (EUV) processes in their advanced chip manufacturing is rapidly increasing. To meet this growing demand, many companies are developing protective films for EUV processes.
ASML launched its first EUV pellicle in 2019 and licensed the technology to Mitsui Chemicals, which began mass sales in 2021. Since then, ASML has made improvements to its pellicle. It is reported that Mitsui Chemicals' next-generation CNT pellicle production facility will be completed by the end of 2025.
In 2021, South Korean company S&S Tech developed a pellicle with a transmittance of more than 90%. FST's EUV pellicle is still in the development stage.
Canatu has been working with Imec since 2015 to develop CNT pellicle to meet performance targets such as life and transmittance, thermal durability, permeability and strength.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global EUV Pellicle market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Mitsui Chemicals
- S&S Tech
- Canatu
- TSMC
- FST
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- ≥90% transmittance
- ＜90% transmittance
Segment by Application
- IDM
- Foundry
CHAPTER OUTLINE
Chapter 1: Defines the EUV Pellicle study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to EUV Pellicle: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global EUV Pellicle Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 ≥90% transmittance
1.2.3 ＜90% transmittance
1.3 Market Segmentation by Application
1.3.1 Global EUV Pellicle Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 IDM
1.3.3 Foundry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global EUV Pellicle Revenue Estimates and Forecasts 2020-2031
2.2 Global EUV Pellicle Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global EUV Pellicle Sales Estimates and Forecasts 2020-2031
2.4 Global EUV Pellicle Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global EUV Pellicle Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 Europe
3.4.2 Japan
3.4.3 South Korea
3.4.4 China Taiwan
4 Competition by Manufacturers
4.1 Global EUV Pellicle Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global EUV Pellicle Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 ≥90% transmittance Market Size by Manufacturers
4.5.2 ＜90% transmittance Market Size by Manufacturers
4.6 Global EUV Pellicle Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global EUV Pellicle Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global EUV Pellicle Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global EUV Pellicle Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global EUV Pellicle Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America EUV Pellicle Sales and Revenue by Type (2020-2031)
7.4 North America EUV Pellicle Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America EUV Pellicle Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe EUV Pellicle Sales and Revenue by Type (2020-2031)
8.4 Europe EUV Pellicle Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe EUV Pellicle Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific EUV Pellicle Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific EUV Pellicle Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific EUV Pellicle Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America EUV Pellicle Sales and Revenue by Type (2020-2031)
10.4 Central and South America EUV Pellicle Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America EUV Pellicle Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa EUV Pellicle Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa EUV Pellicle Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa EUV Pellicle Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Mitsui Chemicals
12.1.1 Mitsui Chemicals Corporation Information
12.1.2 Mitsui Chemicals Business Overview
12.1.3 Mitsui Chemicals EUV Pellicle Product Models, Descriptions and Specifications
12.1.4 Mitsui Chemicals EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Mitsui Chemicals EUV Pellicle Sales by Product in 2024
12.1.6 Mitsui Chemicals EUV Pellicle Sales by Application in 2024
12.1.7 Mitsui Chemicals EUV Pellicle Sales by Geographic Area in 2024
12.1.8 Mitsui Chemicals EUV Pellicle SWOT Analysis
12.1.9 Mitsui Chemicals Recent Developments
12.2 S&S Tech
12.2.1 S&S Tech Corporation Information
12.2.2 S&S Tech Business Overview
12.2.3 S&S Tech EUV Pellicle Product Models, Descriptions and Specifications
12.2.4 S&S Tech EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 S&S Tech EUV Pellicle Sales by Product in 2024
12.2.6 S&S Tech EUV Pellicle Sales by Application in 2024
12.2.7 S&S Tech EUV Pellicle Sales by Geographic Area in 2024
12.2.8 S&S Tech EUV Pellicle SWOT Analysis
12.2.9 S&S Tech Recent Developments
12.3 Canatu
12.3.1 Canatu Corporation Information
12.3.2 Canatu Business Overview
12.3.3 Canatu EUV Pellicle Product Models, Descriptions and Specifications
12.3.4 Canatu EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Canatu EUV Pellicle Sales by Product in 2024
12.3.6 Canatu EUV Pellicle Sales by Application in 2024
12.3.7 Canatu EUV Pellicle Sales by Geographic Area in 2024
12.3.8 Canatu EUV Pellicle SWOT Analysis
12.3.9 Canatu Recent Developments
12.4 TSMC
12.4.1 TSMC Corporation Information
12.4.2 TSMC Business Overview
12.4.3 TSMC EUV Pellicle Product Models, Descriptions and Specifications
12.4.4 TSMC EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 TSMC EUV Pellicle Sales by Product in 2024
12.4.6 TSMC EUV Pellicle Sales by Application in 2024
12.4.7 TSMC EUV Pellicle Sales by Geographic Area in 2024
12.4.8 TSMC EUV Pellicle SWOT Analysis
12.4.9 TSMC Recent Developments
12.5 FST
12.5.1 FST Corporation Information
12.5.2 FST Business Overview
12.5.3 FST EUV Pellicle Product Models, Descriptions and Specifications
12.5.4 FST EUV Pellicle Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 FST EUV Pellicle Sales by Product in 2024
12.5.6 FST EUV Pellicle Sales by Application in 2024
12.5.7 FST EUV Pellicle Sales by Geographic Area in 2024
12.5.8 FST EUV Pellicle SWOT Analysis
12.5.9 FST Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 EUV Pellicle Industry Chain
13.2 EUV Pellicle Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 EUV Pellicle Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 EUV Pellicle Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 EUV Pellicle Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global EUV Pellicle Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global EUV Pellicle Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global EUV Pellicle Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global EUV Pellicle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global EUV Pellicle Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global EUV Pellicle Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global EUV Pellicle Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Sqm)
Table 7. Global EUV Pellicle Sales by Region (2020-2025) & (K Sqm)
Table 8. Global EUV Pellicle Sales by Region (2026-2031) & (K Sqm)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global EUV Pellicle Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Sqm)
Table 11. Global EUV Pellicle Production by Region (2020-2025) & (K Sqm)
Table 12. Global EUV Pellicle Production by Region (2026-2031) & (K Sqm)
Table 13. Global EUV Pellicle Sales by Manufacturers (2020-2025) & (K Sqm)
Table 14. Global EUV Pellicle Sales Share by Manufacturers (2020-2025)
Table 15. Global EUV Pellicle Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global EUV Pellicle Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global EUV Pellicle by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EUV Pellicle as of 2024)
Table 19. Global EUV Pellicle Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global EUV Pellicle Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Sq m)
Table 21. Key Manufacturers EUV Pellicle Manufacturing Base and Headquarters
Table 22. Global EUV Pellicle Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global EUV Pellicle Sales by Type (2020-2025) & (K Sqm)
Table 26. Global EUV Pellicle Sales by Type (2026-2031) & (K Sqm)
Table 27. Global EUV Pellicle Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global EUV Pellicle Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global EUV Pellicle ASP by Type (2020-2031) & (US$/Sq m)
Table 30. Technical Specifications by Key Product Type
Table 31. Global EUV Pellicle Sales by Application (2020-2025) & (K Sqm)
Table 32. Global EUV Pellicle Sales by Application (2026-2031) & (K Sqm)
Table 33. EUV Pellicle High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global EUV Pellicle Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global EUV Pellicle Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global EUV Pellicle ASP by Application (2020-2031) & (US$/Sq m)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America EUV Pellicle Growth Accelerators and Market Barriers
Table 40. North America EUV Pellicle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America EUV Pellicle Sales (K Sqm) by Country (2020 VS 2024 VS 2031)
Table 42. Europe EUV Pellicle Growth Accelerators and Market Barriers
Table 43. Europe EUV Pellicle Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe EUV Pellicle Sales (K Sqm) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific EUV Pellicle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific EUV Pellicle Sales (K Sqm) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific EUV Pellicle Growth Accelerators and Market Barriers
Table 48. Southeast Asia EUV Pellicle Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America EUV Pellicle Investment Opportunities and Key Challenges
Table 50. Central and South America EUV Pellicle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa EUV Pellicle Investment Opportunities and Key Challenges
Table 52. Middle East and Africa EUV Pellicle Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Mitsui Chemicals Corporation Information
Table 54. Mitsui Chemicals Description and Major Businesses
Table 55. Mitsui Chemicals Product Models, Descriptions and Specifications
Table 56. Mitsui Chemicals Capacity, Sales (K Sqm), Revenue (US$ Million), Price (US$/Sq m) and Gross Margin (2020-2025)
Table 57. Mitsui Chemicals Sales Value Proportion by Product in 2024
Table 58. Mitsui Chemicals Sales Value Proportion by Application in 2024
Table 59. Mitsui Chemicals Sales Value Proportion by Geographic Area in 2024
Table 60. Mitsui Chemicals EUV Pellicle SWOT Analysis
Table 61. Mitsui Chemicals Recent Developments
Table 62. S&S Tech Corporation Information
Table 63. S&S Tech Description and Major Businesses
Table 64. S&S Tech Product Models, Descriptions and Specifications
Table 65. S&S Tech Capacity, Sales (K Sqm), Revenue (US$ Million), Price (US$/Sq m) and Gross Margin (2020-2025)
Table 66. S&S Tech Sales Value Proportion by Product in 2024
Table 67. S&S Tech Sales Value Proportion by Application in 2024
Table 68. S&S Tech Sales Value Proportion by Geographic Area in 2024
Table 69. S&S Tech EUV Pellicle SWOT Analysis
Table 70. S&S Tech Recent Developments
Table 71. Canatu Corporation Information
Table 72. Canatu Description and Major Businesses
Table 73. Canatu Product Models, Descriptions and Specifications
Table 74. Canatu Capacity, Sales (K Sqm), Revenue (US$ Million), Price (US$/Sq m) and Gross Margin (2020-2025)
Table 75. Canatu Sales Value Proportion by Product in 2024
Table 76. Canatu Sales Value Proportion by Application in 2024
Table 77. Canatu Sales Value Proportion by Geographic Area in 2024
Table 78. Canatu EUV Pellicle SWOT Analysis
Table 79. Canatu Recent Developments
Table 80. TSMC Corporation Information
Table 81. TSMC Description and Major Businesses
Table 82. TSMC Product Models, Descriptions and Specifications
Table 83. TSMC Capacity, Sales (K Sqm), Revenue (US$ Million), Price (US$/Sq m) and Gross Margin (2020-2025)
Table 84. TSMC Sales Value Proportion by Product in 2024
Table 85. TSMC Sales Value Proportion by Application in 2024
Table 86. TSMC Sales Value Proportion by Geographic Area in 2024
Table 87. TSMC EUV Pellicle SWOT Analysis
Table 88. TSMC Recent Developments
Table 89. FST Corporation Information
Table 90. FST Description and Major Businesses
Table 91. FST Product Models, Descriptions and Specifications
Table 92. FST Capacity, Sales (K Sqm), Revenue (US$ Million), Price (US$/Sq m) and Gross Margin (2020-2025)
Table 93. FST Sales Value Proportion by Product in 2024
Table 94. FST Sales Value Proportion by Application in 2024
Table 95. FST Sales Value Proportion by Geographic Area in 2024
Table 96. FST EUV Pellicle SWOT Analysis
Table 97. FST Recent Developments
Table 98. Key Raw Materials Distribution
Table 99. Raw Materials Key Suppliers
Table 100. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 101. Milestones in Production Technology Evolution
Table 102. Distributors List
Table 103. Market Trends and Market Evolution
Table 104. Market Drivers and Opportunities
Table 105. Market Challenges, Risks, and Restraints
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. EUV Pellicle Product Picture
Figure 2. Global EUV Pellicle Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. ≥90% transmittance Product Picture
Figure 4. ＜90% transmittance Product Picture
Figure 5. Global EUV Pellicle Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. IDM
Figure 7. Foundry
Figure 8. EUV Pellicle Report Years Considered
Figure 9. Global EUV Pellicle Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 11. Global EUV Pellicle Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global EUV Pellicle Revenue Market Share by Region (2020-2031)
Figure 13. Global EUV Pellicle Sales (2020-2031) & (K Sqm)
Figure 14. Global EUV Pellicle Sales (CAGR) by Region (2020-2031) (K Sqm)
Figure 15. Global EUV Pellicle Sales Market Share by Region (2020-2031)
Figure 16. Global EUV Pellicle Capacity, Production and Utilization (2020-2031) & (K Sqm)
Figure 17. Global EUV Pellicle Production Trend by Region (2020-2031) (K Sqm)
Figure 18. Global EUV Pellicle Production Market Share by Region (2020-2031)
Figure 19. Production Capacity Enablers & Constraints
Figure 20. EUV Pellicle Production Growth Rate in Europe (2020-2031) & (K Sqm)
Figure 21. EUV Pellicle Production Growth Rate in Japan (2020-2031) & (K Sqm)
Figure 22. EUV Pellicle Production Growth Rate in South Korea (2020-2031) & (K Sqm)
Figure 23. EUV Pellicle Production Growth Rate in China Taiwan (2020-2031) & (K Sqm)
Figure 24. Top 5 and Top 10 Manufacturers EUV Pellicle Sales Volume Market Share in 2024
Figure 25. Global EUV Pellicle Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. ≥90% transmittance Revenue Market Share by Manufacturer in 2024
Figure 28. ＜90% transmittance Revenue Market Share by Manufacturer in 2024
Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 31. Global EUV Pellicle Sales Market Share by Type (2020-2031)
Figure 32. Global EUV Pellicle Revenue Market Share by Type (2020-2031)
Figure 33. Global EUV Pellicle Sales Market Share by Application (2020-2031)
Figure 34. Global EUV Pellicle Revenue Market Share by Application (2020-2031)
Figure 35. North America EUV Pellicle Sales YoY (2020-2031) & (K Sqm)
Figure 36. North America EUV Pellicle Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers EUV Pellicle Sales Revenue (US$ Million) in 2024
Figure 38. North America EUV Pellicle Sales Volume (K Sqm) by Type (2020- 2031)
Figure 39. North America EUV Pellicle Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America EUV Pellicle Sales Volume (K Sqm) by Application (2020-2031)
Figure 41. North America EUV Pellicle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 43. Canada EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 45. Europe EUV Pellicle Sales YoY (2020-2031) & (K Sqm)
Figure 46. Europe EUV Pellicle Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers EUV Pellicle Sales Revenue (US$ Million) in 2024
Figure 48. Europe EUV Pellicle Sales Volume (K Sqm) by Type (2020-2031)
Figure 49. Europe EUV Pellicle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe EUV Pellicle Sales Volume (K Sqm) by Application (2020-2031)
Figure 51. Europe EUV Pellicle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 53. France EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 55. Italy EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 56. Russia EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific EUV Pellicle Sales YoY (2020-2031) & (K Sqm)
Figure 58. Asia-Pacific EUV Pellicle Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers EUV Pellicle Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific EUV Pellicle Sales Volume (K Sqm) by Type (2020- 2031)
Figure 61. Asia-Pacific EUV Pellicle Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific EUV Pellicle Sales Volume (K Sqm) by Application (2020-2031)
Figure 63. Asia-Pacific EUV Pellicle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 65. Japan EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 68. India EUV Pellicle Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America EUV Pellicle Sales YoY (2020-2031) & (K Sqm)
Figure 70. Central and South America EUV Pellicle Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers EUV Pellicle Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America EUV Pellicle Sales Volume (K Sqm) by Type (2021-2031)
Figure 73. Central and South America EUV Pellicle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America EUV Pellicle Sales Volume (K Sqm) by Application (2020-2031)
Figure 75. Central and South America EUV Pellicle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil EUV Pellicle Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina EUV Pellicle Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa EUV Pellicle Sales YoY (2020-2031) & (K Sqm)
Figure 79. Middle East and Africa EUV Pellicle Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers EUV Pellicle Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa EUV Pellicle Sales Volume (K Sqm) by Type (2021-2031)
Figure 82. South America EUV Pellicle Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa EUV Pellicle Sales Volume (K Sqm) by Application (2020-2031)
Figure 84. Middle East and Africa EUV Pellicle Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries EUV Pellicle Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey EUV Pellicle Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt EUV Pellicle Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa EUV Pellicle Revenue (2020-2025) & (US$ Million)
Figure 89. EUV Pellicle Industry Chain Mapping
Figure 90. Regional EUV Pellicle Manufacturing Base Distribution (%)
Figure 91. EUV Pellicle Production Process
Figure 92. Regional EUV Pellicle Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of EUV Pellicle in 2025?
The global market size of EUV Pellicle in 2025 was 104 Million USD.
What is the annual compound growth rate of the global EUV Pellicle market size from 2025 to 2031?
What was the global market size of EUV Pellicle in 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global EUV Pellicle market?
Related Reports
Global EUV Pellicle Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global EUV Pellicle market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 184 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 75
USD 4250.00
(Single User License)
EUV Pellicle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for EUV Pellicle was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 184 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 84
USD 3950.00
(Single User License)
Global EUV Pellicle Market Research Report 2026
The global EUV Pellicle market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 184 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 119
USD 2900.00
(Single User License)
Global EUV Pellicle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global EUV Pellicle market size was US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 71
USD 4250.00
(Single User License)
Global EUV Pellicle Market Insights, Forecast to 2031
Valued at US$ 104 million in 2024, the global EUV Pellicle market is forecast to reach US$ 171 million by 2030, at a CAGR of 8.6% during the forecast period.
Published Date: 2025-02-16
Pages: 116
USD 4900.00
(Single User License)
EUV Pellicle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for EUV Pellicle was estimated to be worth US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published Date: 2025-02-16
Pages: 85
USD 3950.00
(Single User License)
Global EUV Pellicle Market Research Report 2025
The global market for EUV Pellicle was valued at US$ 78.8 million in the year 2024 and is projected to reach a revised size of US$ 171 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published Date: 2025-02-16
Pages: 84
USD 2900.00
(Single User License)
EUV Pellicle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for EUV Pellicle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 117
USD 3950.00
(Single User License)
Global EUV Pellicle Market Research Report 2024
The global EUV Pellicle market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 97
USD 2900.00
(Single User License)
Global EUV Pellicle Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global EUV Pellicle market size was US$ 104 million in 2025 and is forecast to reach a readjusted size of US$ 184 million by 2032 with a CAGR of 8.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 75
USD 4250.00 (Single User License)EUV Pellicle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for EUV Pellicle was estimated to be worth US$ 104 million in 2025 and is projected to reach US$ 184 million, growing at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-06
Pages: 84
USD 3950.00 (Single User License)Global EUV Pellicle Market Research Report 2026
The global EUV Pellicle market was valued at US$ 104 million in 2025 and is anticipated to reach US$ 184 million by 2032, at a CAGR of 8.6% from 2026 to 2032.
Published: 2026-03-06
Pages: 119
USD 2900.00 (Single User License)Global EUV Pellicle Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global EUV Pellicle market size was US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 71
USD 4250.00 (Single User License)Global EUV Pellicle Market Insights, Forecast to 2031
Valued at US$ 104 million in 2024, the global EUV Pellicle market is forecast to reach US$ 171 million by 2030, at a CAGR of 8.6% during the forecast period.
Published: 2025-02-16
Pages: 116
USD 4900.00 (Single User License)EUV Pellicle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for EUV Pellicle was estimated to be worth US$ 78.8 million in 2024 and is forecast to a readjusted size of US$ 171 million by 2031 with a CAGR of 8.6% during the forecast period 2025-2031.
Published: 2025-02-16
Pages: 85
USD 3950.00 (Single User License)Global EUV Pellicle Market Research Report 2025
The global market for EUV Pellicle was valued at US$ 78.8 million in the year 2024 and is projected to reach a revised size of US$ 171 million by 2031, growing at a CAGR of 8.6% during the forecast period.
Published: 2025-02-16
Pages: 84
USD 2900.00 (Single User License)EUV Pellicle- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for EUV Pellicle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 117
USD 3950.00 (Single User License)Global EUV Pellicle Market Research Report 2024
The global EUV Pellicle market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 97
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now